Trial Profile
An Open-Label, Bilaterally-Controlled Single Center Study to Compare the Efficacy of Taclonex Ointment With Hydrogel Patch Occlusion to Taclonex Ointment Without Occlusion in the Treatment of Plaque-Type Psoriasis
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 22 Apr 2019
Price :
$35
*
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 13 Nov 2018 Status changed to discontinued.
- 04 Dec 2012 Actual patient number changed from 35 to 30 as reported by ClinicalTrials.gov.
- 21 Jan 2010 Actual end date (December 2009) added as reported by ClinicalTrials.gov.